Triveni says: I bought it as it has glutathione
The likelihood of being tumor-free five years after treatment with 5% 5-FU was 70.0%, with MAL-PDT was 62.7% and 80.5% for imiquimod
--- Typical Subcut Protocol (Research Context) Based on available literature and community protocols: Dose: 0.52 mg subcutaneous, once daily Cycle: 48 weeks on, 24 weeks off Reconstitution: Bacteriostatic water (0.9% benzyl alcohol) stable for 46 weeks refrigerated Injection site: Abdomen or thigh, rotated Stacking: Compatible with MOTS-C, BPC-157, and growth hormone secretagogues no known interference Note: GHK-Cu at higher doses can cause a transient copper taste or mild nausea in some users
In combination with copper(II) ions, it modulates over 4,000 genes and is considered one of the most extensively researched peptides in the fields of skin regeneration, wound healing, and anti-aging research
The human airway receives many insults from pathogens, pollen, dust, etc., every day that can contribute to illness, and people who have predispositions to deficiencies in mucus clearance are far more likely to experience an insult that tips their airway from maintaining homeostasis to cycling indefinitely between mucus hypersecretion, dehydration, plugging, and infection